Skip to main content

Table 2 Different pathological types and subtypes of the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 PathologyNo. of patients
TypesNHL15 (45.5%)
HL17 (51.5%)
GALT1 (3.0%)
SubtypesNHL-DLBCL12 (36.4%)
NHL-TCL1 (3%)
NHL-F2 (6%)
HL-NS10 (30.3%)
HL-MC5 (15.2%)
HL-LP2 (6%)
GALT1 (3%)